Dementia risk: why where you live may matter as much as how you live

Dementia risk is shaped not only by individual behavior but by where a person happens to live, according to a large study analyzing data from more than 214,000 people across multiple countries, which found that the relative importance of known risk factors shifts significantly depending on region.
The research builds on more than a decade of work identifying modifiable risk factors for dementia — conditions and behaviors that, unlike age or genetics, can in principle be changed. Previous large-scale analyses, notably from the Lancet Commission on dementia prevention, have estimated that around 40% of dementia cases worldwide could theoretically be delayed or prevented by addressing a shared list of roughly a dozen factors, including hearing loss, high blood pressure, smoking, obesity, diabetes, physical inactivity, depression, social isolation, excessive alcohol use, air pollution and lower educational attainment.
What the new study adds is evidence that these factors do not carry equal weight everywhere. In some countries, hypertension emerged as the single largest contributor to population-level dementia risk, while in others, low educational attainment or air pollution accounted for a larger share, reflecting differences in public health infrastructure, environmental exposure and healthcare access between regions.
The researchers say this variation argues against treating dementia prevention as a one-size-fits-all checklist to be applied uniformly across countries. A national health strategy built around, say, hearing-aid access might meaningfully reduce dementia risk in a country where untreated hearing loss is common, while delivering much smaller returns in a country where the bigger driver is uncontrolled blood pressure.
At the same time, the study found some patterns held remarkably steady across every region examined. Hypertension and hearing loss appeared among the leading modifiable risk factors almost everywhere, regardless of a country's income level or healthcare system, suggesting these two conditions deserve priority in almost any national prevention strategy, even as the surrounding mix of factors shifts.
The mechanisms linking these risk factors to dementia are increasingly well understood. Chronic high blood pressure damages small blood vessels in the brain over years, contributing to vascular dementia and compounding Alzheimer's-related pathology. Untreated hearing loss is thought to accelerate cognitive decline both by depriving the brain of auditory stimulation and by increasing social isolation, itself an independent risk factor, as people withdraw from conversations they struggle to follow.
Air pollution's role, more prominent in the new data for certain heavily industrialized or traffic-dense regions, has grown from a suspected to a well-documented risk factor over the past decade, with fine particulate matter linked to neuroinflammation and accelerated brain aging in multiple longitudinal studies.
The researchers frame their findings as a call for national and regional health authorities to identify which risk factors weigh most heavily in their own populations, using local data rather than importing prevention priorities wholesale from studies conducted elsewhere, typically in wealthier countries with different exposure profiles.
For individuals, the practical implication is less about geography itself and more about not assuming a single global list applies equally everywhere: managing blood pressure and treating hearing loss promptly emerge as close to universally valuable steps, while other priorities — reducing air pollution exposure, addressing social isolation, or expanding access to education — may matter more or less depending on where someone lives.
The study's authors say the next phase of their work will look at whether tailoring public health messaging and screening programs to a country's specific risk profile measurably improves dementia prevention outcomes compared with generic global guidance, a question they argue has significant implications for how limited public health budgets are best allocated.
Read next

Second death reported in New York City legionnaires' disease outbreak
A second person has died in a legionnaires' disease outbreak that has sickened dozens of people in New York City, health officials say, even as they report evidence the source of the bacteria has likely been eliminated.

A common antidepressant may ease long COVID's crushing fatigue, trial finds
A randomized clinical trial of nearly 400 adults found that fluvoxamine, a low-cost, decades-old antidepressant, significantly reduced fatigue and improved quality of life in people with long COVID, making it one of the first medications to show a meaningful benefit for the debilitating symptom.

Mineral sunscreen without the chalky white cast: what UCLA's new formula changes
Mineral sunscreens are prized for being gentler on skin than chemical alternatives, but they have long left users with a visible white cast. Scientists at UCLA say they have redesigned the zinc oxide particles at the heart of the problem, aiming to make mineral sunscreen usable across all skin tones.

Menopause hormone therapy: what it actually treats, and what it doesn't
Menopause hormone therapy has swung from being widely feared to widely recommended, but doctors say expectations have overtaken the evidence. Here is what the treatment reliably helps with, what it doesn't, and how the science has shifted over two decades.

FDA still points to Taylor Farms lettuce in cyclospora outbreak despite a faulty test
US regulators say they remain focused on lettuce supplied by Taylor Farms as the likely source of a multistate cyclospora outbreak, even after one laboratory test used to support that theory turned out to be faulty. Restaurant visits tied to the outbreak have started to decline.